{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044346","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.492020+00:00","generated_at":"2026-05-30T02:46:05.944143+00:00","sec_items":["3.03","8.01","5.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Qualigen Therapeutics effects 1-for-50 reverse stock split to regain Nasdaq compliance","bullets":["Reverse stock split at 1:50 ratio effective 12:01 a.m. ET on November 5, 2024.","Reduces outstanding shares from ~36.8M to approx. 736k shares; no change in authorized shares.","No fractional shares; cash in lieu paid at $5.055 per pre-split share (closing price on Nov 4).","Intended to meet Nasdaq $1.00 minimum bid price requirement (Rule 5550(a)(2)).","Trading symbol remains QLGN; CUSIP changed to 74754R 301."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044346","json":"https://secwatch.observer/filing/0001493152-24-044346.json","markdown":"https://secwatch.observer/filing/0001493152-24-044346.md","text":"https://secwatch.observer/filing/0001493152-24-044346.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/0001493152-24-044346-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:46:05.944143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}